JP2008525314A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008525314A5 JP2008525314A5 JP2007531116A JP2007531116A JP2008525314A5 JP 2008525314 A5 JP2008525314 A5 JP 2008525314A5 JP 2007531116 A JP2007531116 A JP 2007531116A JP 2007531116 A JP2007531116 A JP 2007531116A JP 2008525314 A5 JP2008525314 A5 JP 2008525314A5
- Authority
- JP
- Japan
- Prior art keywords
- gastric
- patient
- symptoms
- paresis
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000002496 gastric effect Effects 0.000 claims 19
- 208000024891 symptom Diseases 0.000 claims 14
- 208000007542 Paresis Diseases 0.000 claims 10
- 239000003795 chemical substances by application Substances 0.000 claims 9
- 230000001225 therapeutic effect Effects 0.000 claims 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 6
- 206010033799 Paralysis Diseases 0.000 claims 6
- 230000000069 prophylactic effect Effects 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 230000003449 preventive effect Effects 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 2
- 208000007882 Gastritis Diseases 0.000 claims 1
- 206010021518 Impaired gastric emptying Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63929104P | 2004-12-28 | 2004-12-28 | |
| PCT/JP2005/024263 WO2006070937A1 (en) | 2004-12-28 | 2005-12-28 | Drugs for the treatment and/or prophylaxis of gastroparesis symptom |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008525314A JP2008525314A (ja) | 2008-07-17 |
| JP2008525314A5 true JP2008525314A5 (https=) | 2009-02-12 |
Family
ID=35985467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007531116A Withdrawn JP2008525314A (ja) | 2004-12-28 | 2005-12-28 | 胃不全麻痺様症状の治療及び／又は予防剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7803779B2 (https=) |
| EP (1) | EP1835920A1 (https=) |
| JP (1) | JP2008525314A (https=) |
| TW (1) | TW200633714A (https=) |
| WO (1) | WO2006070937A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7582611B2 (en) | 2005-05-24 | 2009-09-01 | Pfizer Inc. | Motilide compounds |
| EP2054429B1 (en) | 2006-09-11 | 2013-11-06 | Tranzyme Pharma, Inc. | Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY113693A (en) * | 1992-05-26 | 2002-05-31 | Chugai Pharmaceutical Co Ltd | Erythromycin derivatives having an enterokinesis stimulating action |
| CA2399198A1 (en) * | 2000-02-18 | 2001-08-23 | Christopher Carreras | Motilide compounds |
| EP1557169A4 (en) * | 2002-10-25 | 2010-09-22 | Chugai Pharmaceutical Co Ltd | MEANS FOR THE TREATMENT AND / OR PREVENTION OF DYSCHEZIA |
-
2005
- 2005-12-27 TW TW094146785A patent/TW200633714A/zh unknown
- 2005-12-28 EP EP05824559A patent/EP1835920A1/en not_active Withdrawn
- 2005-12-28 JP JP2007531116A patent/JP2008525314A/ja not_active Withdrawn
- 2005-12-28 WO PCT/JP2005/024263 patent/WO2006070937A1/en not_active Ceased
- 2005-12-28 US US11/813,026 patent/US7803779B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528713A5 (https=) | ||
| JP2009533356A5 (https=) | ||
| JP2006516648A5 (https=) | ||
| RU2011108026A (ru) | Комбинированная терапия туберкулеза | |
| JP2010518122A5 (https=) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2007519649A5 (https=) | ||
| JP2016164165A5 (https=) | ||
| WO2011005811A8 (en) | Combination therapy for the treatment of diabetes | |
| JP2008534453A5 (https=) | ||
| WO2007112000A3 (en) | Treatment of pain | |
| JP2006516272A5 (https=) | ||
| NO20050569L (no) | Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette | |
| JP2009513713A5 (https=) | ||
| JP2002525266A5 (https=) | ||
| RU2001107149A (ru) | Тауролидин и/или таурултам против инфекционной язвенной болезни или инфекционного гастрита | |
| JP2012508256A5 (https=) | ||
| JPWO2023054732A5 (https=) | ||
| WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
| JP2011500589A5 (https=) | ||
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| CA2565993A1 (en) | Salt of 4-or 5- aminosalicylic acid | |
| CA2964684A1 (en) | Composition for the treatment of conditions involving muscular pain | |
| EA200601286A1 (ru) | Фармацевтические композиции, содержащие ингибитор протонового насоса и прокинетический агент | |
| JP2012504584A5 (https=) |